Stansberry Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $6.54M | Buy |
|
|||||
|
2025
Q1 | $6.58M | Buy |
|
|||||
|
2024
Q4 | $7.45M | Buy |
|
|||||
|
2024
Q3 | $7.43M | Buy |
|
|||||
|
2024
Q2 | $8.46M | Buy |
|
|||||
|
2024
Q1 | $6.68M | Buy |
|
|||||
|
2023
Q4 | $4.48M | Sell |
|
|||||
|
2023
Q3 | $4.27M | Buy |
|
|||||
|
2023
Q2 | $3.75M | Buy |
|
|||||
|
2023
Q1 | $3.49M | Buy |
|
|||||
|
2022
Q4 | $1.65M | Buy |
|
|||||
|
2022
Q3 | $994K | Buy |
|
|||||
|
2022
Q2 | $1.02M | Sell |
|
|||||
|
2022
Q1 | $1.05M | Buy |
|
|||||
|
2021
Q4 | $638K | Buy |
|
|||||
|
2021
Q3 | $398K | Buy |
|
|||||
|
2021
Q2 | $299K | Buy |
|